Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propolis Administration in Type 2 Diabetes
NCT06903546Phase 4Recruiting
- Sponsor
- Universitas Indonesia
- Start
- Mar 2025
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Low Density Lipoprotein at 8 weeks and High Density Lipoprotein at 8 weeks. Started Mar 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06903546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06903546.